76
Views
8
CrossRef citations to date
0
Altmetric
Original Research

MiR-139-5p Targetedly Regulates YAF2 and Mediates the AKT/P38 MAPK Signaling Pathway to Alleviate the Metastasis of Non-Small Cell Lung Cancer Cells and Their Resistance Against Cisplatin

, , , , , & show all
Pages 3639-3650 | Published online: 05 May 2021

References

  • Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67(3):177–193.28248415
  • Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.28055103
  • Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.26808342
  • Wood SL, Pernemalm M, Crosbie PA, Whetton AD. Molecular histology of lung cancer: from targets to treatments. Cancer Treat Rev. 2015;41(4):361–375.25825324
  • Cekaite L, Eide PW, Lind GE, Skotheim RI, Lothe RA. MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer. Oncotarget. 2016;7(6):6476–6505.26623728
  • Abba ML, Patil N, Leupold JH, et al. MicroRNAs as novel targets and tools in cancer therapy. Cancer Lett. 2017;387:84–94.27045478
  • Mazza T, Gioffreda D, Fontana A, et al. Clinical Significance of Circulating miR-1273g-3p and miR-122-5p in Pancreatic Cancer. Front Oncol. 2020;10:44.32117716
  • Zarredar H, Ansarin K, Baradaran B, et al. Critical microRNAs in Lung Cancer: recent Advances and Potential Applications. Anticancer Agents Med Chem. 2018;18(14):1991–2005.30088452
  • Sun K, Hu P, Xu F. LINC00152/miR-139-5p regulates gastric cancer cell aerobic glycolysis by targeting PRKAA1. Biomed Pharmacother. 2018;97:1296–1302.29156518
  • Ji X, Guo H, Yin S, Du H. miR-139-5p functions as a tumor suppressor in cervical cancer by targeting TCF4 and inhibiting Wnt/beta-catenin signaling. Onco Targets Ther. 2019;12:7739–7748.31571923
  • Cao T, Feng DU, Tingyu LI, Yuanyuan LU, Zhao X. The miR-139-5p regulates proliferation, migration and invasion in KRAS-mutated colon cancer cells. Theranostics. 2017;10:7335.
  • Jiang Y, Jiang J, Jia H, Qiao Z, Zhang J. Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun. Cell Physiol Biochem. 2018;51(1):129–141.30439707
  • Hou C, Ma X, Chen H, Huang B, Chen D. YAF2 promotes tumor cell proliferation via targeting cyclin D1 expression. Basic Clin Med. 2018;38(6):764–770.
  • Wang V, Wu W. MicroRNA-based therapeutics for cancer. BioDrugs. 2009;23(1):15–23.19344188
  • Duz MB, Karatas OF, Guzel E, et al. Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot study. Cell Oncol. 2016;39(2):187–193.
  • Tan W, Liao Y, Qiu Y, et al. miRNA 146a promotes chemotherapy resistance in lung cancer cells by targeting DNA damage inducible transcript 3 (CHOP). Cancer Lett. 2018;428:55–68.29702190
  • Wang L, Li X, Ren Y, et al. Cancer-associated fibroblasts contribute to cisplatin resistance by modulating ANXA3 in lung cancer cells. Cancer Sci. 2019;110(5):1609–1620.30868675
  • Ye L, Pu C, Tang J, et al. Transmembrane-4 L-six family member-1 (TM4SF1) promotes non-small cell lung cancer proliferation, invasion and chemo-resistance through regulating the DDR1/Akt/ERK-mTOR axis. Respir Res. 2019;20(1):106.31142317
  • Yong-Hao Y, Xian-Guo W, Ming X, Jin-Ping Z. Expression and clinical significance of miR-139-5p in non-small cell lung cancer. J Int Med Res. 2019;47(2):867–874.30614351
  • Zeng F, Yu N, Han Y, Ainiwaer J. The long non-coding RNA MIAT/miR-139-5p/MMP2 axis regulates cell migration and invasion in non-small-cell lung cancer. J Biosci. 2020;45(1):1–12.31965979
  • Zhang Z, Li W, Jiang D, Liu C, Lai Z. MicroRNA-139-5p inhibits cell viability, migration and invasion and suppresses tumor growth by targeting HDGF in non-small cell lung cancer. Oncol Lett. 2020;19(3):1806–1814.32194674
  • Jiao W, Zhang J, Wei Y, et al. MiR-139-5p regulates VEGFR and downstream signaling pathways to inhibit the development of esophageal cancer. Dig Liver Dis. 2019;51(1):149–156.30245290
  • Liu J, Li C, Jiang Y, Wan Y, Zhou S, Cheng W. Tumor-suppressor role of miR-139-5p in endometrial cancer. Cancer Cell Int. 2018;18:51.29618950
  • Xu K, Shen K, Liang X, et al. MiR-139-5p reverses CD44+/CD133+-associated multidrug resistance by downregulating NOTCH1 in colorectal carcinoma cells. Oncotarget. 2016;7(46):75118–75129.27738333
  • Zhao W, Liu M, Ji H, et al. The polycomb group protein Yaf2 regulates the pluripotency of embryonic stem cells in a phosphorylation-dependent manner. J Biol Chem. 2018;293(33):12793–12804.29959227
  • Basu A, Wilkinson FH, Colavita K, Fennelly C, Atchison ML. YY1 DNA binding and interaction with YAF2 is essential for Polycomb recruitment. Nucleic Acids Res. 2014;42(4):2208–2223.24285299
  • Zhuang XF, Zhao LX, Guo SP, Wei S, Zhai JF, Zhou QH. miR-34b inhibits the migration/invasion and promotes apoptosis of non-small-cell lung cancer cells by YAF2. Eur Rev Med Pharmacol Sci. 2019;23(5):2038–2046.30915747
  • Nagappan A, Lee WS, Yun JW, et al. Tetraarsenic hexoxide induces G2/M arrest, apoptosis, and autophagy via PI3K/Akt suppression and p38 MAPK activation in SW620 human colon cancer cells. PLoS One. 2017;12(3):e0174591.28355296
  • Das U, Manna K, Adhikary A, et al. Ferulic acid enhances the radiation sensitivity of lung and liver carcinoma cells by collapsing redox homeostasis: mechanistic involvement of Akt/p38 MAPK signalling pathway. Free Radic Res. 2019;53(9–10):944–967.31576765